2015 - 2015
- Cooperated with National Taiwan University Hospital to establish “AMD Research Center”.
- Signed co-develop contract (SB04) with AJU PHARM Korea.
SB01 phase 2 clinical trial for head and neck cancer was approved by TFDA and FDA.
SB01 phase 2 clinical trial for head and neck cancer was approved by TFDA and FDA.